Global Advanced Therapy Medicinal Products CDMO Market Size, Share & Industry Trends Analysis Report By Indication, By Product (Gene Therapy, Cell Therapy, and Tissue Engineered & Others), By Phase (Phase I, Phase II, Phase III, and Phase IV), By Regional Outlook and Forecast, 2022 - 2028

The Global Advanced Therapy Medicinal Products CDMO Market size is expected to reach $11.9 billion by 2028, rising at a market growth of 16.3% CAGR during the forecast period.

Advanced therapy medical products CDMO are organizations that fall under the category of contract development and manufacturing organizations (CDMO) that offer services for the processing of advanced therapy products. Advanced Therapy Medicinal Products (ATMPs) are advanced therapeutic medications that are focused on gene therapy or cell therapy.

CDMOs primarily support their clientele in the process of drug discovery through the provision of manufacturing capabilities and also help the pharmaceutical industry as a whole. The increase in the number of molecular drug approvals, the growing prevalence of infectious diseases, and the growing favorability for innovative therapeutics demand are inducing a rise in the number of CDMO setups in order to facilitate the quick development and production of therapies.

Because of this, the research, knowledge, and manufacturing capabilities of CDMOs are absolutely essential for moving the drug development process forward. Innovative treatments such as somatic cell therapy, gene therapy, and tissue-engineered products are all included in the category of advanced therapy medical products. It is expected that these therapies would deliver significant health advantages.

Medications derived through gene therapy contain genes that have been shown to have a curative, preventative, or diagnostic function. In most cases, they are used to treat a wide range of ailments, such as genetic disorders, cancer, or diseases that have a protracted course of treatment, and they function by introducing recombinant genes into the body. Additionally, a segment of DNA known as a recombinant gene is one that has been synthesized in the lab by combining strands of DNA derived from a variety of different sources.

COVID-19 Impact Analysis

Mesenchymal stem cells (MSCs), an ATMP, also offered a cutting-edge approach to treating the COVID-19 virus. Due to the challenging nature of the manufacturing process, the COVID-19 pandemic has had a substantial impact on the cell and gene therapy sector. Tissue engineering has significantly benefited from recent technology advancements. Damaged organs and tissues can be replaced or have their functionality restored with this technique. Similar to this, cell and gene therapy are attracting a lot of interest from patients in order to treat rare diseases, which are growing globally. Therefore, the pandemic affected the advanced therapy medicinal products CDMO market positively.

Market Growth Factors

Rising Need for CDMOS Due to Increasing Number of ATMP Clinical Trials

The growing number of clinical studies for advanced therapy medicinal products is one of the key factors driving the need for CDMOs. There were 3,579 gene, cell, and RNA therapies in development as of Q1 2022, according to a study by the American Society of Gene and Cell Therapy. According to the research, as of Q1 2021, the pipeline for gene cell therapy has grown by 16%. Genetically engineered cell therapies are being outperformed in the pipeline by CAR-T cell therapies. Furthermore, 98% of CAR-T cell treatments are still being developed for cancer-related indications. All these factors influence an increase in the number of CDMO and thus promote the growth of the advanced therapy medicinal products CDMO market.

Increasing efforts to develop novel therapies for various diseases

The effect of rising product demand around the world is a significant market trend that has prompted the development of novel therapeutic solutions. Over the course of the projection period, increasing product demand and significant increase in gene and cell therapies are anticipated to fuel growth opportunities for the market. CDMO assures the complete solution, starting with the planning of clinical trials and concluding with drug production. While CDMOs can prepare the drug, pharmaceutical and biopharmaceutical companies increase their research to develop innovative and efficient medicines. Therefore, each of these reasons contributes to the expansion of the advanced therapy medicinal products CDMO market.

Market Restraining Factors

Specific drawbacks of cell therapy methods of ATMP

Stem cell therapy's primary limitation is that the cells of a single origin can only make cells of the same origin and type, for example, brain cells can only produce more brain cells. This is one of the procedure's most significant downsides. The utilization of cell therapies would become more constrained as a result of these drawbacks. Since the use of stem cell therapy can result in the destruction of human embryos, one might expect to see a decline in the demand for these therapies. In addition, it is expected that the risk of contamination and the possibility of technological malfunctions may act as a barrier to the expansion of the automated cell therapy processing systems, which would hamper the growth of the advanced therapy medicinal products CDMO market.

Product Outlook

Based on product, the advanced therapy medicinal products CDMO market is segmented into gene therapy, cell therapy, tissue engineered and others. The cell therapy segment procured a considerable growth rate in the advanced therapy medicinal products CDMO market in 2021. New cell types are continuously being introduced to the domain of cellular therapies, which presents numerous chances for businesses to strengthen their market positions. The significant unmet need for cell therapy production, the recent approval of sophisticated medicines, and the demonstrated efficacy of these products are also drawing new players to the industry. These factors are therefore, propelling the expansion of the segment.

Phase Outlook

On the basis of phase, the advanced therapy medicinal products CDMO market is bifurcated into phase I, phase II, phase III, and phase IV. The phase I segment acquired the largest revenue share in the advanced therapy medicinal products CDMO market in 2021. The segment's expansion can be attributed to rising R&D efforts and an increase in the number of advanced therapy human trials. Phase 1 assists in ensuring a drug's safety levels when it is given to a small group of patients in a variety of doses and dosing formats. The major goal of this phase is to ascertain the largest dose a patient may get without experiencing any negative effects.

Indication Outlook

By indication, the advanced therapy medicinal products CDMO market is fragmented into oncology, cardiology, central nervous system & musculoskeletal, infectious disease, dermatology, endocrine, metabolic, genetic, immunology & inflammation, ophthalmology, hematology, gastroenterology, and others. The oncology segment witnessed the maximum revenue share in the advanced therapy medicinal products CDMO market in 2021. The prevalence of the disease, the strategic actions made by key competitors, and the accessibility of cutting-edge medicines utilized to treat various cancer indications are all contributing factors to the segment's rise. Oncology clinical trials include all phases of the process where Phase I trials determines dose and phase II analyses define efficacy in a single tumor type.

Advanced Therapy Medicinal Products CDMO Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 4.2 Billion
Market size forecast in 2028	USD 11.9 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 16.3% from 2022 to 2028
Number of Pages	282
Number of Tables	443
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Indication, Product, Phase, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Rising Need for CDMOS Due to Increasing Number of ATMP Clinical Trials Increasing efforts to develop novel therapies for various diseases
Restraints	Specific drawbacks of cell therapy methods of ATMP

Regional Outlook

Region wise, the advanced therapy medicinal products CDMO market is analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region recorded the highest revenue share in the advanced therapy medicinal products CDMO market in 2021. This can be due to rising interest in innovative therapies and rising outsourcing activities. The growing burden of diseases like cardiovascular, cancer, and certain rare genetic disorders have raised the levels of research and funding for the development of ATMPs that may serve as treatment methods for these diseases. It is projected that America will maintain its position as a leader in R&D for cutting-edge treatments in the coming years.

Free Valuable Insights: Global Advanced Therapy Medicinal Products CDMO Market size to reach USD 11.9 Billion by 2028

KBV Cardinal Matrix - Advanced Therapy Medicinal Products CDMO Market Competition Analysis

The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Thermo Fisher Scientific, Inc. (Patheon, Inc.) and Lonza Group AG are the forerunners in the Advanced Therapy Medicinal Products CDMO Market. Companies such as AGC Biologics, Inc., WuXi Advanced Therapies, and Catalent, Inc. are some of the key innovators in Advanced Therapy Medicinal Products CDMO Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc. (Patheon, Inc.), AGC Biologics, Inc. (AGC, Inc.), Catalent, Inc., Minaris Regenerative Medicine GmbH (Resonac Holdings Corporation), WuXi AppTec Co., Ltd. (WuXi Advanced Therapies), Lonza Group AG, Celonic AG (JRS PHARMA GmbH & Co. KG), Rentschler Biopharma SE, and Bio Elpida (Polyplus-transfection SA.).

Strategies deployed in Advanced Therapy Medicinal Products CDMO Market

» Partnerships, Collaborations and Agreements:

• Jan-2023: Catalent came into agreement with Sarepta Therapeutics, a US-based provider of precision genetic medicines. The commercial supply agreement involves Catalent manufacturing Sarepta’s gene therapy delandistrogene moxeparvovec (SRP-9001) meant for the treatment of Duchenne muscular dystrophy (DMD).
• Aug-2022: AGC Biologics partnered with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs). The partnership involves cashing on RoosterBio’s media and cell products and AGC's gene and cell therapy manufacturing abilities, to develop an end-to-end solution for the production and expansion of exosome and hMSC therapeutics that help media and cell growth services.
• Apr-2022: WuXi Advanced Therapies partnered with Bioprocessing Technology Institute, a Singapore-based research institute. The partnership involves accelerating cell and gene therapy products in the APAC region, and focuses on WuXi ATU’s Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) technology that enhances adeno-associated virus (AAV) yields and particle quality.
• Feb-2021: Rentschler Biopharma SE signed an agreement with Cell and Gene Therapy Catapult (CGT Catapult), an independent center of excellence in innovation advancing the UK's cell and gene therapy industry. The agreement involves leveraging Catapult's expertise to set up a manufacturing capability in advanced therapy medicinal products intended for clinical trial supply at Catapult's manufacturing facility in Stevenage, England.
• Nov-2020: Lonza came into partnership with Be The Match BioTherapies, an organization offering solutions for companies developing and commercializing cell and gene therapies. Through this partnership, the company aims to offer end-to-end solutions that advance the growth of cell and gene therapies throughout the CGT supply chain.
• Feb-2020: Catalent signed a contract with Zumutor Biologics, a US-based biotechnology company, primarily into providing NK cell therapeutics. The agreement involves manufacturing Zumutor’s ZM008 meant for solid tumor treatment.

» Product Launches and Product Expansions:

• May-2020: WuXi Advanced Therapies launched the CAR-T Cell Therapy Platform. A platform intended for advanced therapy companies providing them with various capabilities including, regulatory and technical expertise, full in-process and release testing, robust quality control, etc. The new platform advances the time taken for cell and gene therapy development, at the same time offering greater definiteness.
• Jan-2020: WuXi Advanced Therapies unveiled the associated virus (AAV) Vector Suspension Platform. The platform supports advancing the timeline for cell and gene therapy development, at the same time offering greater predictability.

» Geographical Expansions:

• Oct-2022: Lonza expanded its laboratory space at its facilities in Houston (US) and Geleen (NL). The capacity expansion is intended to expand the CGT process and analytical development. Moreover, the expansion reinforces Lonza's global process development service offerings.
• May-2022: AGC Biologics expanded its production capacity at its plant in Colorado, US to cater to the strong demand for cell and gene therapy.
• Mar-2021: AGC expanded its geographical footprint by installing new viral vector production equipment at its facility in Milan, Italy. The new equipment would allow AGC to implement a platform best suited for the large-scale manufacturing of viral vectors.

» Acquisitions and Mergers:

• Aug-2022: Catalent acquired Metrics Contract Services (Metrics), a US-based organization, primarily into providing contract development and manufacturing services for the medical sector. The acquisition advances Catalent's ability to better serve its clients, particularly those clients with R & D pipelines having rare, orphan, diseases for oncology and other therapeutic areas.
• Apr-2022: Catalent took over Erytech's cell Therapy Development and Manufacturing Facility in Princeton, New Jersey. The 30,900-square-foot manufacturing plant's acquisition reflects Catalent's devotion to fulfilling the growing demand for cell therapies.
• Aug-2021: AGC Biologics acquired a commercial facility in Longmont, Colorado, USA from Novartis Gene Therapies. The acquisition expands AGC's manufacturing capacity supporting its global end-to-end Cell and Gene Therapy (C&GT) offerings and further expanding cell and gene therapy presence in the US.
• Mar-2021: WuXi AppTec acquired OXGENE, a pioneering United Kingdom-based contract research, and development organization. Through this acquisition, the company aims to provide its customers with end-to-end aid in the development and creation of advanced cell and gene therapies.
• Jul-2020: AGC took over MolMed, an Italy-based biotechnology company. The acquisition brings in MolMed's expertise and competence in development and GMP manufacturing services to AGC Biologics' global CDMO service offerings.

Scope of the Study

Market Segments Covered in the Report:

By Indication

• Oncology
• Cardiology
• Central Nervous System & Musculoskeletal
• Infectious Disease
• Dermatology
• Endocrine, Metabolic, Genetic
• Immunology & Inflammation
• Ophthalmology
• Hematology
• Gastroenterology
• Others

By Product

• Gene Therapy
• Cell Therapy
• Tissue Engineered & Others

By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Thermo Fisher Scientific, Inc. (Patheon, Inc.)
• AGC Biologics, Inc. (AGC, Inc.)
• Catalent, Inc.
• Minaris Regenerative Medicine GmbH (Resonac Holdings Corporation)
• WuXi AppTec Co., Ltd. (WuXi Advanced Therapies)
• Lonza Group AG
• Celonic AG (JRS PHARMA GmbH & Co. KG)
• Rentschler Biopharma SE
• Bio Elpida (Polyplus-transfection SA.)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Advanced Therapy Medicinal Products CDMO Market, by Indication
1.4.2 Global Advanced Therapy Medicinal Products CDMO Market, by Product
1.4.3 Global Advanced Therapy Medicinal Products CDMO Market, by Phase
1.4.4 Global Advanced Therapy Medicinal Products CDMO Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers : 2019, Jan – 2022, Aug) Leading Players

Chapter 4. Global Advanced Therapy Medicinal Products CDMO Market by Indication
4.1 Global Oncology Market by Region
4.2 Global Cardiology Market by Region
4.3 Global Central Nervous System & Musculoskeletal Market by Region
4.4 Global Infectious Disease Market by Region
4.5 Global Dermatology Market by Region
4.6 Global Endocrine, Metabolic, Genetic Market by Region
4.7 Global Immunology & Inflammation Market by Region
4.8 Global Ophthalmology Market by Region
4.9 Global Hematology Market by Region
4.1 Global Gastroenterology Market by Region
4.11 Global Others Market by Region

Chapter 5. Global Advanced Therapy Medicinal Products CDMO Market by Product
5.1 Global Gene Therapy Market by Region
5.2 Global Cell Therapy Market by Region
5.3 Global Tissue Engineered & Others Market by Region

Chapter 6. Global Advanced Therapy Medicinal Products CDMO Market by Phase
6.1 Global Phase I Market by Region
6.2 Global Phase II Market by Region
6.3 Global Phase III Market by Region
6.4 Global Phase IV Market by Region

Chapter 7. Global Advanced Therapy Medicinal Products CDMO Market by Region
7.1 North America Advanced Therapy Medicinal Products CDMO Market
7.1.1 North America Advanced Therapy Medicinal Products CDMO Market by Indication
7.1.1.1 North America Oncology Market by Country
7.1.1.2 North America Cardiology Market by Country
7.1.1.3 North America Central Nervous System & Musculoskeletal Market by Country
7.1.1.4 North America Infectious Disease Market by Country
7.1.1.5 North America Dermatology Market by Country
7.1.1.6 North America Endocrine, Metabolic, Genetic Market by Country
7.1.1.7 North America Immunology & Inflammation Market by Country
7.1.1.8 North America Ophthalmology Market by Country
7.1.1.9 North America Hematology Market by Country
7.1.1.10 North America Gastroenterology Market by Country
7.1.1.11 North America Others Market by Country
7.1.2 North America Advanced Therapy Medicinal Products CDMO Market by Product
7.1.2.1 North America Gene Therapy Market by Country
7.1.2.2 North America Cell Therapy Market by Country
7.1.2.3 North America Tissue Engineered & Others Market by Country
7.1.3 North America Advanced Therapy Medicinal Products CDMO Market by Phase
7.1.3.1 North America Phase I Market by Country
7.1.3.2 North America Phase II Market by Country
7.1.3.3 North America Phase III Market by Country
7.1.3.4 North America Phase IV Market by Country
7.1.4 North America Advanced Therapy Medicinal Products CDMO Market by Country
7.1.4.1 US Advanced Therapy Medicinal Products CDMO Market
7.1.4.1.1 US Advanced Therapy Medicinal Products CDMO Market by Indication
7.1.4.1.2 US Advanced Therapy Medicinal Products CDMO Market by Product
7.1.4.1.3 US Advanced Therapy Medicinal Products CDMO Market by Phase
7.1.4.2 Canada Advanced Therapy Medicinal Products CDMO Market
7.1.4.2.1 Canada Advanced Therapy Medicinal Products CDMO Market by Indication
7.1.4.2.2 Canada Advanced Therapy Medicinal Products CDMO Market by Product
7.1.4.2.3 Canada Advanced Therapy Medicinal Products CDMO Market by Phase
7.1.4.3 Mexico Advanced Therapy Medicinal Products CDMO Market
7.1.4.3.1 Mexico Advanced Therapy Medicinal Products CDMO Market by Indication
7.1.4.3.2 Mexico Advanced Therapy Medicinal Products CDMO Market by Product
7.1.4.3.3 Mexico Advanced Therapy Medicinal Products CDMO Market by Phase
7.1.4.4 Rest of North America Advanced Therapy Medicinal Products CDMO Market
7.1.4.4.1 Rest of North America Advanced Therapy Medicinal Products CDMO Market by Indication
7.1.4.4.2 Rest of North America Advanced Therapy Medicinal Products CDMO Market by Product
7.1.4.4.3 Rest of North America Advanced Therapy Medicinal Products CDMO Market by Phase
7.2 Europe Advanced Therapy Medicinal Products CDMO Market
7.2.1 Europe Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.1.1 Europe Oncology Market by Country
7.2.1.2 Europe Cardiology Market by Country
7.2.1.3 Europe Central Nervous System & Musculoskeletal Market by Country
7.2.1.4 Europe Infectious Disease Market by Country
7.2.1.5 Europe Dermatology Market by Country
7.2.1.6 Europe Endocrine, Metabolic, Genetic Market by Country
7.2.1.7 Europe Immunology & Inflammation Market by Country
7.2.1.8 Europe Ophthalmology Market by Country
7.2.1.9 Europe Hematology Market by Country
7.2.1.10 Europe Gastroenterology Market by Country
7.2.1.11 Europe Others Market by Country
7.2.2 Europe Advanced Therapy Medicinal Products CDMO Market by Product
7.2.2.1 Europe Gene Therapy Market by Country
7.2.2.2 Europe Cell Therapy Market by Country
7.2.2.3 Europe Tissue Engineered & Others Market by Country
7.2.3 Europe Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.3.1 Europe Phase I Market by Country
7.2.3.2 Europe Phase II Market by Country
7.2.3.3 Europe Phase III Market by Country
7.2.3.4 Europe Phase IV Market by Country
7.2.4 Europe Advanced Therapy Medicinal Products CDMO Market by Country
7.2.4.1 Germany Advanced Therapy Medicinal Products CDMO Market
7.2.4.1.1 Germany Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.1.2 Germany Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.1.3 Germany Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.4.2 UK Advanced Therapy Medicinal Products CDMO Market
7.2.4.2.1 UK Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.2.2 UK Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.2.3 UK Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.4.3 France Advanced Therapy Medicinal Products CDMO Market
7.2.4.3.1 France Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.3.2 France Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.3.3 France Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.4.4 Russia Advanced Therapy Medicinal Products CDMO Market
7.2.4.4.1 Russia Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.4.2 Russia Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.4.3 Russia Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.4.5 Spain Advanced Therapy Medicinal Products CDMO Market
7.2.4.5.1 Spain Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.5.2 Spain Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.5.3 Spain Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.4.6 Italy Advanced Therapy Medicinal Products CDMO Market
7.2.4.6.1 Italy Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.6.2 Italy Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.6.3 Italy Advanced Therapy Medicinal Products CDMO Market by Phase
7.2.4.7 Rest of Europe Advanced Therapy Medicinal Products CDMO Market
7.2.4.7.1 Rest of Europe Advanced Therapy Medicinal Products CDMO Market by Indication
7.2.4.7.2 Rest of Europe Advanced Therapy Medicinal Products CDMO Market by Product
7.2.4.7.3 Rest of Europe Advanced Therapy Medicinal Products CDMO Market by Phase
7.3 Asia Pacific Advanced Therapy Medicinal Products CDMO Market
7.3.1 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.1.1 Asia Pacific Oncology Market by Country
7.3.1.2 Asia Pacific Cardiology Market by Country
7.3.1.3 Asia Pacific Central Nervous System & Musculoskeletal Market by Country
7.3.1.4 Asia Pacific Infectious Disease Market by Country
7.3.1.5 Asia Pacific Dermatology Market by Country
7.3.1.6 Asia Pacific Endocrine, Metabolic, Genetic Market by Country
7.3.1.7 Asia Pacific Immunology & Inflammation Market by Country
7.3.1.8 Asia Pacific Ophthalmology Market by Country
7.3.1.9 Asia Pacific Hematology Market by Country
7.3.1.10 Asia Pacific Gastroenterology Market by Country
7.3.1.11 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Product
7.3.2.1 Asia Pacific Gene Therapy Market by Country
7.3.2.2 Asia Pacific Cell Therapy Market by Country
7.3.2.3 Asia Pacific Tissue Engineered & Others Market by Country
7.3.3 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.3.1 Asia Pacific Phase I Market by Country
7.3.3.2 Asia Pacific Phase II Market by Country
7.3.3.3 Asia Pacific Phase III Market by Country
7.3.3.4 Asia Pacific Phase IV Market by Country
7.3.4 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Country
7.3.4.1 China Advanced Therapy Medicinal Products CDMO Market
7.3.4.1.1 China Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.1.2 China Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.1.3 China Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.4.2 Japan Advanced Therapy Medicinal Products CDMO Market
7.3.4.2.1 Japan Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.2.2 Japan Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.2.3 Japan Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.4.3 India Advanced Therapy Medicinal Products CDMO Market
7.3.4.3.1 India Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.3.2 India Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.3.3 India Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.4.4 South Korea Advanced Therapy Medicinal Products CDMO Market
7.3.4.4.1 South Korea Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.4.2 South Korea Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.4.3 South Korea Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.4.5 Singapore Advanced Therapy Medicinal Products CDMO Market
7.3.4.5.1 Singapore Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.5.2 Singapore Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.5.3 Singapore Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.4.6 Malaysia Advanced Therapy Medicinal Products CDMO Market
7.3.4.6.1 Malaysia Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.6.2 Malaysia Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.6.3 Malaysia Advanced Therapy Medicinal Products CDMO Market by Phase
7.3.4.7 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market
7.3.4.7.1 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Indication
7.3.4.7.2 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Product
7.3.4.7.3 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Phase
7.4 LAMEA Advanced Therapy Medicinal Products CDMO Market
7.4.1 LAMEA Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.1.1 LAMEA Oncology Market by Country
7.4.1.2 LAMEA Cardiology Market by Country
7.4.1.3 LAMEA Central Nervous System & Musculoskeletal Market by Country
7.4.1.4 LAMEA Infectious Disease Market by Country
7.4.1.5 LAMEA Dermatology Market by Country
7.4.1.6 LAMEA Endocrine, Metabolic, Genetic Market by Country
7.4.1.7 LAMEA Immunology & Inflammation Market by Country
7.4.1.8 LAMEA Ophthalmology Market by Country
7.4.1.9 LAMEA Hematology Market by Country
7.4.1.10 LAMEA Gastroenterology Market by Country
7.4.1.11 LAMEA Others Market by Country
7.4.2 LAMEA Advanced Therapy Medicinal Products CDMO Market by Product
7.4.2.1 LAMEA Gene Therapy Market by Country
7.4.2.2 LAMEA Cell Therapy Market by Country
7.4.2.3 LAMEA Tissue Engineered & Others Market by Country
7.4.3 LAMEA Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.3.1 LAMEA Phase I Market by Country
7.4.3.2 LAMEA Phase II Market by Country
7.4.3.3 LAMEA Phase III Market by Country
7.4.3.4 LAMEA Phase IV Market by Country
7.4.4 LAMEA Advanced Therapy Medicinal Products CDMO Market by Country
7.4.4.1 Brazil Advanced Therapy Medicinal Products CDMO Market
7.4.4.1.1 Brazil Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.1.2 Brazil Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.1.3 Brazil Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.4.2 Argentina Advanced Therapy Medicinal Products CDMO Market
7.4.4.2.1 Argentina Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.2.2 Argentina Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.2.3 Argentina Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.4.3 UAE Advanced Therapy Medicinal Products CDMO Market
7.4.4.3.1 UAE Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.3.2 UAE Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.3.3 UAE Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.4.4 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market
7.4.4.4.1 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.4.2 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.4.3 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.4.5 South Africa Advanced Therapy Medicinal Products CDMO Market
7.4.4.5.1 South Africa Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.5.2 South Africa Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.5.3 South Africa Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.4.6 Nigeria Advanced Therapy Medicinal Products CDMO Market
7.4.4.6.1 Nigeria Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.6.2 Nigeria Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.6.3 Nigeria Advanced Therapy Medicinal Products CDMO Market by Phase
7.4.4.7 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market
7.4.4.7.1 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market by Indication
7.4.4.7.2 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market by Product
7.4.4.7.3 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market by Phase

Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc. (Patheon, Inc.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 AGC Biologics, Inc. (AGC, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.2.5.3 Geographical Expansions:
8.3 Catalent, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Minaris Regenerative Medicine GmbH (Resonac Holdings Corporation)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 WuXi AppTec Co., Ltd. (WuXi Advanced Therapies)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Product Launches and Product Expansions:
8.5.4.2 Acquisition and Mergers:
8.5.4.3 Partnerships, Collaborations, and Agreements:
8.6 Lonza Group AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Geographical Expansions:
8.7 Celonic AG (JRS PHARMA GmbH & Co. KG)
8.7.1 Company Overview
8.8 Bio Elpida (Polyplus-transfection SA.)
8.8.1 Company Overview
8.9 Rentschler Biopharma SE
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Acquisition and Mergers:

TABLE 1 Global Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 2 Global Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Advanced Therapy Medicinal Products CDMO Market
TABLE 4 Product Launches And Product Expansions– Advanced Therapy Medicinal Products CDMO Market
TABLE 5 Acquisition and Mergers– Advanced Therapy Medicinal Products CDMO Market
TABLE 6 geographical expansions – Advanced Therapy Medicinal Products CDMO Market
TABLE 7 Global Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 8 Global Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 9 Global Oncology Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Oncology Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Cardiology Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Cardiology Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Central Nervous System & Musculoskeletal Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Central Nervous System & Musculoskeletal Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Infectious Disease Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Infectious Disease Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Dermatology Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Dermatology Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Endocrine, Metabolic, Genetic Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Endocrine, Metabolic, Genetic Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Immunology & Inflammation Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Immunology & Inflammation Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Ophthalmology Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Ophthalmology Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Hematology Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Hematology Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Gastroenterology Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Gastroenterology Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 32 Global Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 33 Global Gene Therapy Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Gene Therapy Market by Region, 2022 - 2028, USD Million
TABLE 35 Global Cell Therapy Market by Region, 2018 - 2021, USD Million
TABLE 36 Global Cell Therapy Market by Region, 2022 - 2028, USD Million
TABLE 37 Global Tissue Engineered & Others Market by Region, 2018 - 2021, USD Million
TABLE 38 Global Tissue Engineered & Others Market by Region, 2022 - 2028, USD Million
TABLE 39 Global Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 40 Global Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 41 Global Phase I Market by Region, 2018 - 2021, USD Million
TABLE 42 Global Phase I Market by Region, 2022 - 2028, USD Million
TABLE 43 Global Phase II Market by Region, 2018 - 2021, USD Million
TABLE 44 Global Phase II Market by Region, 2022 - 2028, USD Million
TABLE 45 Global Phase III Market by Region, 2018 - 2021, USD Million
TABLE 46 Global Phase III Market by Region, 2022 - 2028, USD Million
TABLE 47 Global Phase IV Market by Region, 2018 - 2021, USD Million
TABLE 48 Global Phase IV Market by Region, 2022 - 2028, USD Million
TABLE 49 Global Advanced Therapy Medicinal Products CDMO Market by Region, 2018 - 2021, USD Million
TABLE 50 Global Advanced Therapy Medicinal Products CDMO Market by Region, 2022 - 2028, USD Million
TABLE 51 North America Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 52 North America Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 53 North America Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 54 North America Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 55 North America Oncology Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Oncology Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Cardiology Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Cardiology Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Central Nervous System & Musculoskeletal Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Central Nervous System & Musculoskeletal Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Infectious Disease Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Infectious Disease Market by Country, 2022 - 2028, USD Million
TABLE 63 North America Dermatology Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Dermatology Market by Country, 2022 - 2028, USD Million
TABLE 65 North America Endocrine, Metabolic, Genetic Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Endocrine, Metabolic, Genetic Market by Country, 2022 - 2028, USD Million
TABLE 67 North America Immunology & Inflammation Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Immunology & Inflammation Market by Country, 2022 - 2028, USD Million
TABLE 69 North America Ophthalmology Market by Country, 2018 - 2021, USD Million
TABLE 70 North America Ophthalmology Market by Country, 2022 - 2028, USD Million
TABLE 71 North America Hematology Market by Country, 2018 - 2021, USD Million
TABLE 72 North America Hematology Market by Country, 2022 - 2028, USD Million
TABLE 73 North America Gastroenterology Market by Country, 2018 - 2021, USD Million
TABLE 74 North America Gastroenterology Market by Country, 2022 - 2028, USD Million
TABLE 75 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 76 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 77 North America Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 78 North America Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 79 North America Gene Therapy Market by Country, 2018 - 2021, USD Million
TABLE 80 North America Gene Therapy Market by Country, 2022 - 2028, USD Million
TABLE 81 North America Cell Therapy Market by Country, 2018 - 2021, USD Million
TABLE 82 North America Cell Therapy Market by Country, 2022 - 2028, USD Million
TABLE 83 North America Tissue Engineered & Others Market by Country, 2018 - 2021, USD Million
TABLE 84 North America Tissue Engineered & Others Market by Country, 2022 - 2028, USD Million
TABLE 85 North America Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 86 North America Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 87 North America Phase I Market by Country, 2018 - 2021, USD Million
TABLE 88 North America Phase I Market by Country, 2022 - 2028, USD Million
TABLE 89 North America Phase II Market by Country, 2018 - 2021, USD Million
TABLE 90 North America Phase II Market by Country, 2022 - 2028, USD Million
TABLE 91 North America Phase III Market by Country, 2018 - 2021, USD Million
TABLE 92 North America Phase III Market by Country, 2022 - 2028, USD Million
TABLE 93 North America Phase IV Market by Country, 2018 - 2021, USD Million
TABLE 94 North America Phase IV Market by Country, 2022 - 2028, USD Million
TABLE 95 North America Advanced Therapy Medicinal Products CDMO Market by Country, 2018 - 2021, USD Million
TABLE 96 North America Advanced Therapy Medicinal Products CDMO Market by Country, 2022 - 2028, USD Million
TABLE 97 US Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 98 US Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 99 US Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 100 US Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 101 US Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 102 US Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 103 US Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 104 US Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 105 Canada Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 106 Canada Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 107 Canada Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 108 Canada Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 109 Canada Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 110 Canada Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 111 Canada Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 112 Canada Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 113 Mexico Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 114 Mexico Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 115 Mexico Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 116 Mexico Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 117 Mexico Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 118 Mexico Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 119 Mexico Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 120 Mexico Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 121 Rest of North America Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 122 Rest of North America Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 123 Rest of North America Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 124 Rest of North America Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 125 Rest of North America Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 126 Rest of North America Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 127 Rest of North America Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 128 Rest of North America Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 129 Europe Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 130 Europe Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 131 Europe Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 132 Europe Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 133 Europe Oncology Market by Country, 2018 - 2021, USD Million
TABLE 134 Europe Oncology Market by Country, 2022 - 2028, USD Million
TABLE 135 Europe Cardiology Market by Country, 2018 - 2021, USD Million
TABLE 136 Europe Cardiology Market by Country, 2022 - 2028, USD Million
TABLE 137 Europe Central Nervous System & Musculoskeletal Market by Country, 2018 - 2021, USD Million
TABLE 138 Europe Central Nervous System & Musculoskeletal Market by Country, 2022 - 2028, USD Million
TABLE 139 Europe Infectious Disease Market by Country, 2018 - 2021, USD Million
TABLE 140 Europe Infectious Disease Market by Country, 2022 - 2028, USD Million
TABLE 141 Europe Dermatology Market by Country, 2018 - 2021, USD Million
TABLE 142 Europe Dermatology Market by Country, 2022 - 2028, USD Million
TABLE 143 Europe Endocrine, Metabolic, Genetic Market by Country, 2018 - 2021, USD Million
TABLE 144 Europe Endocrine, Metabolic, Genetic Market by Country, 2022 - 2028, USD Million
TABLE 145 Europe Immunology & Inflammation Market by Country, 2018 - 2021, USD Million
TABLE 146 Europe Immunology & Inflammation Market by Country, 2022 - 2028, USD Million
TABLE 147 Europe Ophthalmology Market by Country, 2018 - 2021, USD Million
TABLE 148 Europe Ophthalmology Market by Country, 2022 - 2028, USD Million
TABLE 149 Europe Hematology Market by Country, 2018 - 2021, USD Million
TABLE 150 Europe Hematology Market by Country, 2022 - 2028, USD Million
TABLE 151 Europe Gastroenterology Market by Country, 2018 - 2021, USD Million
TABLE 152 Europe Gastroenterology Market by Country, 2022 - 2028, USD Million
TABLE 153 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 154 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 155 Europe Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 156 Europe Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 157 Europe Gene Therapy Market by Country, 2018 - 2021, USD Million
TABLE 158 Europe Gene Therapy Market by Country, 2022 - 2028, USD Million
TABLE 159 Europe Cell Therapy Market by Country, 2018 - 2021, USD Million
TABLE 160 Europe Cell Therapy Market by Country, 2022 - 2028, USD Million
TABLE 161 Europe Tissue Engineered & Others Market by Country, 2018 - 2021, USD Million
TABLE 162 Europe Tissue Engineered & Others Market by Country, 2022 - 2028, USD Million
TABLE 163 Europe Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 164 Europe Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 165 Europe Phase I Market by Country, 2018 - 2021, USD Million
TABLE 166 Europe Phase I Market by Country, 2022 - 2028, USD Million
TABLE 167 Europe Phase II Market by Country, 2018 - 2021, USD Million
TABLE 168 Europe Phase II Market by Country, 2022 - 2028, USD Million
TABLE 169 Europe Phase III Market by Country, 2018 - 2021, USD Million
TABLE 170 Europe Phase III Market by Country, 2022 - 2028, USD Million
TABLE 171 Europe Phase IV Market by Country, 2018 - 2021, USD Million
TABLE 172 Europe Phase IV Market by Country, 2022 - 2028, USD Million
TABLE 173 Europe Advanced Therapy Medicinal Products CDMO Market by Country, 2018 - 2021, USD Million
TABLE 174 Europe Advanced Therapy Medicinal Products CDMO Market by Country, 2022 - 2028, USD Million
TABLE 175 Germany Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 176 Germany Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 177 Germany Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 178 Germany Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 179 Germany Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 180 Germany Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 181 Germany Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 182 Germany Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 183 UK Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 184 UK Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 185 UK Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 186 UK Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 187 UK Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 188 UK Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 189 UK Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 190 UK Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 191 France Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 192 France Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 193 France Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 194 France Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 195 France Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 196 France Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 197 France Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 198 France Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 199 Russia Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 200 Russia Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 201 Russia Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 202 Russia Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 203 Russia Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 204 Russia Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 205 Russia Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 206 Russia Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 207 Spain Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 208 Spain Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 209 Spain Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 210 Spain Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 211 Spain Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 212 Spain Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 213 Spain Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 214 Spain Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 215 Italy Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 216 Italy Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 217 Italy Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 218 Italy Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 219 Italy Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 220 Italy Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 221 Italy Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 222 Italy Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 223 Rest of Europe Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 224 Rest of Europe Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 225 Rest of Europe Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 226 Rest of Europe Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 227 Rest of Europe Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 228 Rest of Europe Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 229 Rest of Europe Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 230 Rest of Europe Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 231 Asia Pacific Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 232 Asia Pacific Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 233 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 234 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 235 Asia Pacific Oncology Market by Country, 2018 - 2021, USD Million
TABLE 236 Asia Pacific Oncology Market by Country, 2022 - 2028, USD Million
TABLE 237 Asia Pacific Cardiology Market by Country, 2018 - 2021, USD Million
TABLE 238 Asia Pacific Cardiology Market by Country, 2022 - 2028, USD Million
TABLE 239 Asia Pacific Central Nervous System & Musculoskeletal Market by Country, 2018 - 2021, USD Million
TABLE 240 Asia Pacific Central Nervous System & Musculoskeletal Market by Country, 2022 - 2028, USD Million
TABLE 241 Asia Pacific Infectious Disease Market by Country, 2018 - 2021, USD Million
TABLE 242 Asia Pacific Infectious Disease Market by Country, 2022 - 2028, USD Million
TABLE 243 Asia Pacific Dermatology Market by Country, 2018 - 2021, USD Million
TABLE 244 Asia Pacific Dermatology Market by Country, 2022 - 2028, USD Million
TABLE 245 Asia Pacific Endocrine, Metabolic, Genetic Market by Country, 2018 - 2021, USD Million
TABLE 246 Asia Pacific Endocrine, Metabolic, Genetic Market by Country, 2022 - 2028, USD Million
TABLE 247 Asia Pacific Immunology & Inflammation Market by Country, 2018 - 2021, USD Million
TABLE 248 Asia Pacific Immunology & Inflammation Market by Country, 2022 - 2028, USD Million
TABLE 249 Asia Pacific Ophthalmology Market by Country, 2018 - 2021, USD Million
TABLE 250 Asia Pacific Ophthalmology Market by Country, 2022 - 2028, USD Million
TABLE 251 Asia Pacific Hematology Market by Country, 2018 - 2021, USD Million
TABLE 252 Asia Pacific Hematology Market by Country, 2022 - 2028, USD Million
TABLE 253 Asia Pacific Gastroenterology Market by Country, 2018 - 2021, USD Million
TABLE 254 Asia Pacific Gastroenterology Market by Country, 2022 - 2028, USD Million
TABLE 255 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 256 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 257 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 258 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 259 Asia Pacific Gene Therapy Market by Country, 2018 - 2021, USD Million
TABLE 260 Asia Pacific Gene Therapy Market by Country, 2022 - 2028, USD Million
TABLE 261 Asia Pacific Cell Therapy Market by Country, 2018 - 2021, USD Million
TABLE 262 Asia Pacific Cell Therapy Market by Country, 2022 - 2028, USD Million
TABLE 263 Asia Pacific Tissue Engineered & Others Market by Country, 2018 - 2021, USD Million
TABLE 264 Asia Pacific Tissue Engineered & Others Market by Country, 2022 - 2028, USD Million
TABLE 265 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 266 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 267 Asia Pacific Phase I Market by Country, 2018 - 2021, USD Million
TABLE 268 Asia Pacific Phase I Market by Country, 2022 - 2028, USD Million
TABLE 269 Asia Pacific Phase II Market by Country, 2018 - 2021, USD Million
TABLE 270 Asia Pacific Phase II Market by Country, 2022 - 2028, USD Million
TABLE 271 Asia Pacific Phase III Market by Country, 2018 - 2021, USD Million
TABLE 272 Asia Pacific Phase III Market by Country, 2022 - 2028, USD Million
TABLE 273 Asia Pacific Phase IV Market by Country, 2018 - 2021, USD Million
TABLE 274 Asia Pacific Phase IV Market by Country, 2022 - 2028, USD Million
TABLE 275 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Country, 2018 - 2021, USD Million
TABLE 276 Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Country, 2022 - 2028, USD Million
TABLE 277 China Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 278 China Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 279 China Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 280 China Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 281 China Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 282 China Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 283 China Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 284 China Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 285 Japan Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 286 Japan Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 287 Japan Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 288 Japan Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 289 Japan Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 290 Japan Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 291 Japan Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 292 Japan Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 293 India Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 294 India Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 295 India Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 296 India Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 297 India Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 298 India Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 299 India Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 300 India Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 301 South Korea Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 302 South Korea Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 303 South Korea Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 304 South Korea Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 305 South Korea Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 306 South Korea Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 307 South Korea Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 308 South Korea Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 309 Singapore Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 310 Singapore Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 311 Singapore Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 312 Singapore Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 313 Singapore Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 314 Singapore Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 315 Singapore Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 316 Singapore Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 317 Malaysia Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 318 Malaysia Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 319 Malaysia Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 320 Malaysia Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 321 Malaysia Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 322 Malaysia Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 323 Malaysia Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 324 Malaysia Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 325 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 326 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 327 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 328 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 329 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 330 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 331 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 332 Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 333 LAMEA Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 334 LAMEA Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 335 LAMEA Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 336 LAMEA Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 337 LAMEA Oncology Market by Country, 2018 - 2021, USD Million
TABLE 338 LAMEA Oncology Market by Country, 2022 - 2028, USD Million
TABLE 339 LAMEA Cardiology Market by Country, 2018 - 2021, USD Million
TABLE 340 LAMEA Cardiology Market by Country, 2022 - 2028, USD Million
TABLE 341 LAMEA Central Nervous System & Musculoskeletal Market by Country, 2018 - 2021, USD Million
TABLE 342 LAMEA Central Nervous System & Musculoskeletal Market by Country, 2022 - 2028, USD Million
TABLE 343 LAMEA Infectious Disease Market by Country, 2018 - 2021, USD Million
TABLE 344 LAMEA Infectious Disease Market by Country, 2022 - 2028, USD Million
TABLE 345 LAMEA Dermatology Market by Country, 2018 - 2021, USD Million
TABLE 346 LAMEA Dermatology Market by Country, 2022 - 2028, USD Million
TABLE 347 LAMEA Endocrine, Metabolic, Genetic Market by Country, 2018 - 2021, USD Million
TABLE 348 LAMEA Endocrine, Metabolic, Genetic Market by Country, 2022 - 2028, USD Million
TABLE 349 LAMEA Immunology & Inflammation Market by Country, 2018 - 2021, USD Million
TABLE 350 LAMEA Immunology & Inflammation Market by Country, 2022 - 2028, USD Million
TABLE 351 LAMEA Ophthalmology Market by Country, 2018 - 2021, USD Million
TABLE 352 LAMEA Ophthalmology Market by Country, 2022 - 2028, USD Million
TABLE 353 LAMEA Hematology Market by Country, 2018 - 2021, USD Million
TABLE 354 LAMEA Hematology Market by Country, 2022 - 2028, USD Million
TABLE 355 LAMEA Gastroenterology Market by Country, 2018 - 2021, USD Million
TABLE 356 LAMEA Gastroenterology Market by Country, 2022 - 2028, USD Million
TABLE 357 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 358 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 359 LAMEA Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 360 LAMEA Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 361 LAMEA Gene Therapy Market by Country, 2018 - 2021, USD Million
TABLE 362 LAMEA Gene Therapy Market by Country, 2022 - 2028, USD Million
TABLE 363 LAMEA Cell Therapy Market by Country, 2018 - 2021, USD Million
TABLE 364 LAMEA Cell Therapy Market by Country, 2022 - 2028, USD Million
TABLE 365 LAMEA Tissue Engineered & Others Market by Country, 2018 - 2021, USD Million
TABLE 366 LAMEA Tissue Engineered & Others Market by Country, 2022 - 2028, USD Million
TABLE 367 LAMEA Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 368 LAMEA Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 369 LAMEA Phase I Market by Country, 2018 - 2021, USD Million
TABLE 370 LAMEA Phase I Market by Country, 2022 - 2028, USD Million
TABLE 371 LAMEA Phase II Market by Country, 2018 - 2021, USD Million
TABLE 372 LAMEA Phase II Market by Country, 2022 - 2028, USD Million
TABLE 373 LAMEA Phase III Market by Country, 2018 - 2021, USD Million
TABLE 374 LAMEA Phase III Market by Country, 2022 - 2028, USD Million
TABLE 375 LAMEA Phase IV Market by Country, 2018 - 2021, USD Million
TABLE 376 LAMEA Phase IV Market by Country, 2022 - 2028, USD Million
TABLE 377 LAMEA Advanced Therapy Medicinal Products CDMO Market by Country, 2018 - 2021, USD Million
TABLE 378 LAMEA Advanced Therapy Medicinal Products CDMO Market by Country, 2022 - 2028, USD Million
TABLE 379 Brazil Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 380 Brazil Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 381 Brazil Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 382 Brazil Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 383 Brazil Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 384 Brazil Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 385 Brazil Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 386 Brazil Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 387 Argentina Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 388 Argentina Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 389 Argentina Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 390 Argentina Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 391 Argentina Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 392 Argentina Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 393 Argentina Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 394 Argentina Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 395 UAE Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 396 UAE Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 397 UAE Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 398 UAE Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 399 UAE Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 400 UAE Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 401 UAE Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 402 UAE Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 403 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 404 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 405 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 406 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 407 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 408 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 409 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 410 Saudi Arabia Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 411 South Africa Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 412 South Africa Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 413 South Africa Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 414 South Africa Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 415 South Africa Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 416 South Africa Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 417 South Africa Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 418 South Africa Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 419 Nigeria Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 420 Nigeria Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 421 Nigeria Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 422 Nigeria Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 423 Nigeria Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 424 Nigeria Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 425 Nigeria Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 426 Nigeria Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 427 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market, 2018 - 2021, USD Million
TABLE 428 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market, 2022 - 2028, USD Million
TABLE 429 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2021, USD Million
TABLE 430 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market by Indication, 2022 - 2028, USD Million
TABLE 431 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2021, USD Million
TABLE 432 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market by Product, 2022 - 2028, USD Million
TABLE 433 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2021, USD Million
TABLE 434 Rest of LAMEA Advanced Therapy Medicinal Products CDMO Market by Phase, 2022 - 2028, USD Million
TABLE 435 Key Information – Thermo Fisher Scientific, Inc.
TABLE 436 Key Information –AGC Biologics, Inc.
TABLE 437 Key information – CATALENT, INC.
TABLE 438 Key Information – Minaris Regenerative Medicine GmbH
TABLE 439 Key Information – WuXi AppTec Co., Ltd.
TABLE 440 Key Information – Lonza Group AG
TABLE 441 Key Information – Celonic AG
TABLE 442 Key Information – Bio Elpida
TABLE 443 Key Information – Rentschler Biopharma SE

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers : 2019, Jan – 2022, Aug) Leading Players
FIG 5 Global Advanced Therapy Medicinal Products CDMO Market share by Indication, 2021
FIG 6 Global Advanced Therapy Medicinal Products CDMO Market share by Indication, 2028
FIG 7 Global Advanced Therapy Medicinal Products CDMO Market by Indication, 2018 - 2028, USD Million
FIG 8 Global Advanced Therapy Medicinal Products CDMO Market share by Product, 2021
FIG 9 Global Advanced Therapy Medicinal Products CDMO Market share by Product, 2028
FIG 10 Global Advanced Therapy Medicinal Products CDMO Market by Product, 2018 - 2028, USD Million
FIG 11 Global Advanced Therapy Medicinal Products CDMO Market share by Phase, 2021
FIG 12 Global Advanced Therapy Medicinal Products CDMO Market share by Phase, 2028
FIG 13 Global Advanced Therapy Medicinal Products CDMO Market by Phase, 2018 - 2028, USD Million
FIG 14 Global Advanced Therapy Medicinal Products CDMO Market share by Region, 2021
FIG 15 Global Advanced Therapy Medicinal Products CDMO Market share by Region, 2028
FIG 16 Global Advanced Therapy Medicinal Products CDMO Market by Region, 2018 - 2028, USD Million
FIG 17 Swot analysis: thermo fisher scientific, inc.
FIG 18 Recent strategies and developments: AGC Biologics, Inc.
FIG 19 Recent strategies and developments: Catalent, Inc.
FIG 20 Recent strategies and developments: WuXi AppTec Co., Ltd.